d-アンフェタミンが誘発した中央ドーパミン神経細胞の阻害:ストライアトニグラフィードバック経路による媒介
まとめ
ストライアト・ニグラス経路の損傷により,d-アンフェタミンが著しく減少します.
科学分野:
- 神経科学は神経科学である.
- 神経薬理学神経薬理学について
- ドーパミナージックシステムの研究
背景:
- 中央ドーパミナージックニューロンは,運動制御と報酬に不可欠です.
- d-アンフェタミンは,ドーパミン活性に影響することが知られている刺激剤です.
- 以前の研究では,アンフェタミンの作用の間接的なメカニズムが示唆されていた.
研究 の 目的:
- ドーパミン細胞に対するd-アンフェタミンの抑うつ効果を媒介するストレイト・ニグラス経路の役割を調査する.
- アンフェタミンの作用に影響を与えるニューロンのフィードバックループの仮説を検証する.
主な方法:
- ストライアト・ニグラス経路の病変を誘発する (大脳核または尾状核の周辺).
- 静脈内投与のd-アンフェタミンを投与し,中央ドーパミン細胞活動に対する効果を観察する.
- 結果を以前のマイクロオントフォレティックアプリケーションデータと比較する.
主要な成果:
- ストライアト・ニグラス経路の損傷は,ドーパミン細胞活動に対するd-アンフェタミンの抑うつ効果を著しく弱めた.
- ドーパミナージック細胞にd-アンフェタミンを直接投与しても,有意な減速は起こらなかった.
- これらの発見は,間接的な作用メカニズムを裏付けている.
結論:
- 中枢ドーパミン細胞に対するd-アンフェタミンの抑うつ効果は,主にストライアトニグラス神経フィードバックループによって媒介されます.
- この経路は,ドーパミン作用神経伝達に対するアンフェタミンの影響を調節するために不可欠です.
- このループを理解することで,アンフェタミンの神経化学的作用についての洞察が得られます.
関連する概念動画
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


